Works matching AU D'Atri, Stefania

Results: 39
    1
    2

    Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2529, doi. 10.1007/s00432-021-03811-3
    By:
    • Verkhovskaia, Sofia;
    • Di Pietro, Francesca Romana;
    • Mastroeni, Simona;
    • Carbone, Maria Luigia;
    • Abeni, Damiano;
    • Morese, Roberto;
    • Morelli, Francesca Maria;
    • D'Atri, Stefania;
    • Marchetti, Paolo;
    • De Galitiis, Federica;
    • Failla, Cristina Maria;
    • Fortes, Cristina
    Publication type:
    Article
    3

    Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-03151-3
    By:
    • Levati, Lauretta;
    • Tabolacci, Claudio;
    • Facchiano, Antonio;
    • Facchiano, Francesco;
    • Alvino, Ester;
    • Antonini Cappellini, Gian Carlo;
    • Scala, Enrico;
    • Bonmassar, Laura;
    • Caporali, Simona;
    • Lacal, Pedro Miguel;
    • Bresin, Antonella;
    • De Galitiis, Federica;
    • Russo, Giandomenico;
    • D'Atri, Stefania
    Publication type:
    Article
    4
    5
    6

    Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.

    Published in:
    Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-023-04776-2
    By:
    • Pallocca, Matteo;
    • Molineris, Ivan;
    • Berrino, Enrico;
    • Marcozzi, Benedetta;
    • Betti, Martina;
    • Levati, Lauretta;
    • D'Atri, Stefania;
    • Menin, Chiara;
    • Madonna, Gabriele;
    • Ghiorzo, Paola;
    • Bulgarelli, Jenny;
    • Ferraresi, Virgina;
    • Venesio, Tiziana;
    • Rodolfo, Monica;
    • Rivoltini, Licia;
    • Lanfrancone, Luisa;
    • Ascierto, Paolo Antonio;
    • Mazzarella, Luca;
    • Pelicci, Pier Giuseppe;
    • De Maria, Ruggero
    Publication type:
    Article
    7
    8
    9

    Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0915-z
    By:
    • Boussadia, Zaira;
    • Lamberti, Jessica;
    • Mattei, Fabrizio;
    • Pizzi, Elisabetta;
    • Puglisi, Rossella;
    • Zanetti, Cristiana;
    • Pasquini, Luca;
    • Fratini, Federica;
    • Fantozzi, Luca;
    • Felicetti, Federica;
    • Fecchi, Katia;
    • Raggi, Carla;
    • Sanchez, Massimo;
    • D'Atri, Stefania;
    • Carè, Alessandra;
    • Sargiacomo, Massimo;
    • Parolini, Isabella
    Publication type:
    Article
    10

    The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2017, v. 36, p. 1, doi. 10.1186/s13046-017-0577-2
    By:
    • Atzori, Maria Grazia;
    • Tentori, Lucio;
    • Ruffini, Federica;
    • Ceci, Claudia;
    • Lisi, Lucia;
    • Bonanno, Elena;
    • Scimeca, Manuel;
    • Eskilsson, Eskil;
    • Daubon, Thomas;
    • Miletic, Hrvoje;
    • Vitiani, Lucia Ricci;
    • Pallini, Roberto;
    • Navarra, Pierluigi;
    • Bjerkvig, Rolf;
    • D'Atri, Stefania;
    • Lacal, Pedro Miguel;
    • Graziani, Grazia
    Publication type:
    Article
    11

    Reversing vemurafenib‐resistance in primary melanoma cells by combined romidepsin and type I IFN treatment through blocking of tumorigenic signals and induction of immunogenic effects.

    Published in:
    International Journal of Cancer, 2023, v. 153, n. 5, p. 1080, doi. 10.1002/ijc.34602
    By:
    • Fragale, Alessandra;
    • Stellacci, Emilia;
    • Romagnoli, Giulia;
    • Licursi, Valerio;
    • Parlato, Stefania;
    • Canini, Irene;
    • Remedi, Giacomo;
    • Buoncervello, Maria;
    • Matarrese, Paola;
    • Pedace, Lucia;
    • Ascione, Barbara;
    • Pizzi, Simone;
    • Tartaglia, Marco;
    • D'Atri, Stefania;
    • Presutti, Carlo;
    • Capone, Imerio;
    • Gabriele, Lucia
    Publication type:
    Article
    12
    13
    14

    Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2.

    Published in:
    Pigment Cell & Melanoma Research, 2015, v. 28, n. 1, p. 73, doi. 10.1111/pcmr.12319
    By:
    • Borsotti, Patrizia;
    • Ghilardi, Carmen;
    • Ostano, Paola;
    • Silini, Antonietta;
    • Dossi, Romina;
    • Pinessi, Denise;
    • Foglieni, Chiara;
    • Scatolini, Maria;
    • Lacal, Pedro M.;
    • Ferrari, Raffaele;
    • Moscatelli, Davide;
    • Sangalli, Fabio;
    • D'Atri, Stefania;
    • Giavazzi, Raffaella;
    • Bani, Maria Rosa;
    • Chiorino, Giovanna;
    • Taraboletti, Giulia
    Publication type:
    Article
    15

    MicroRNA-155 targets the SKI gene in human melanoma cell lines.

    Published in:
    Pigment Cell & Melanoma Research, 2011, v. 24, n. 3, p. 538, doi. 10.1111/j.1755-148X.2011.00857.x
    By:
    • Levati, Lauretta;
    • Pagani, Elena;
    • Romani, Sveva;
    • Castiglia, Daniele;
    • Piccinni, Eugenia;
    • Covaciu, Claudia;
    • Caporaso, Patrizia;
    • Bondanza, Sergio;
    • Antonetti, Francesca R.;
    • Bonmassar, Enzo;
    • Martelli, Fabio;
    • Alvino, Ester;
    • D'Atri, Stefania
    Publication type:
    Article
    16

    Correction to: Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.

    Published in:
    2024
    By:
    • Pallocca, Matteo;
    • Molineris, Ivan;
    • Berrino, Enrico;
    • Marcozzi, Benedetta;
    • Betti, Martina;
    • Levati, Lauretta;
    • D'Atri, Stefania;
    • Menin, Chiara;
    • Madonna, Gabriele;
    • Ghiorzo, Paola;
    • Bulgarelli, Jenny;
    • Ferraresi, Virgina;
    • Venesio, Tiziana;
    • Rodolfo, Monica;
    • Rivoltini, Licia;
    • Lanfrancone, Luisa;
    • Ascierto, Paolo Antonio;
    • Mazzarella, Luca;
    • Pelicci, Pier Giuseppe;
    • De Maria, Ruggero
    Publication type:
    Correction Notice
    17
    18
    19

    miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1238-4
    By:
    • Caporali, Simona;
    • Amaro, Adriana;
    • Levati, Lauretta;
    • Alvino, Ester;
    • Lacal, Pedro Miguel;
    • Mastroeni, Simona;
    • Ruffini, Federica;
    • Bonmassar, Laura;
    • Antonini Cappellini, Gian Carlo;
    • Felli, Nadia;
    • Carè, Alessandra;
    • Pfeffer, Ulrich;
    • D'Atri, Stefania
    Publication type:
    Article
    20

    Melanoma and Vitiligo: In Good Company.

    Published in:
    International Journal of Molecular Sciences, 2019, v. 20, n. 22, p. 5731, doi. 10.3390/ijms20225731
    By:
    • Failla, Cristina Maria;
    • Carbone, Maria Luigia;
    • Fortes, Cristina;
    • Pagnanelli, Gianluca;
    • D'Atri, Stefania
    Publication type:
    Article
    21

    Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma.

    Published in:
    Biomedicines, 2021, v. 9, n. 12, p. 1930, doi. 10.3390/biomedicines9121930
    By:
    • Tosi, Anna;
    • Nardinocchi, Lavinia;
    • Carbone, Maria Luigia;
    • Capriotti, Lorena;
    • Pagani, Elena;
    • Mastroeni, Simona;
    • Fortes, Cristina;
    • Scopelliti, Fernanda;
    • Cattani, Caterina;
    • Passarelli, Francesca;
    • Rosato, Antonio;
    • D'Atri, Stefania;
    • Failla, Cristina Maria;
    • Cavani, Andrea
    Publication type:
    Article
    22
    23

    Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy.

    Published in:
    Cancers, 2022, v. 14, n. 15, p. 3706, doi. 10.3390/cancers14153706
    By:
    • Levati, Lauretta;
    • Bassi, Cristian;
    • Mastroeni, Simona;
    • Lupini, Laura;
    • Antonini Cappellini, Gian Carlo;
    • Bonmassar, Laura;
    • Alvino, Ester;
    • Caporali, Simona;
    • Lacal, Pedro Miguel;
    • Narducci, Maria Grazia;
    • Molineris, Ivan;
    • De Galitiis, Federica;
    • Negrini, Massimo;
    • Russo, Giandomenico;
    • D'Atri, Stefania
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway.

    Published in:
    Journal of Translational Medicine, 2015, v. 13, p. 1, doi. 10.1186/1479-5876-13-S1-P5
    By:
    • Caporali, Simona;
    • Alvino, Ester;
    • Amaro, Adriana;
    • Lacal, Pedro Miguel;
    • Levati, Lauretta;
    • Atzori, Maria Grazia;
    • Antonini Cappellini, Gian Carlo;
    • Ruffini, Federica;
    • Bonmassar, Enzo;
    • Pfeffer, Ulrich;
    • D'Atri, Stefania
    Publication type:
    Article
    38

    Loss of miR-204 expression is a key event in melanoma.

    Published in:
    Molecular Cancer, 2018, v. 17, n. 1, p. 1, doi. 10.1186/s12943-018-0819-8
    By:
    • Galasso, Marco;
    • Morrison, Carl;
    • Minotti, Linda;
    • Corrà, Fabio;
    • Zerbinati, Carlotta;
    • Agnoletto, Chiara;
    • Baldassari, Federica;
    • Fassan, Matteo;
    • Bartolazzi, Armando;
    • Vecchione, Andrea;
    • Nuovo, Gerard J.;
    • Di Leva, Gianpiero;
    • D’Atri, Stefania;
    • Alvino, Ester;
    • Previati, Maurizio;
    • Nickoloff, Brian J.;
    • Croce, Carlo M.;
    • Volinia, Stefano
    Publication type:
    Article
    39